ZA904599B - Stable freeze dried polyhematoporphyrin ether/ester composition - Google Patents

Stable freeze dried polyhematoporphyrin ether/ester composition

Info

Publication number
ZA904599B
ZA904599B ZA904599A ZA904599A ZA904599B ZA 904599 B ZA904599 B ZA 904599B ZA 904599 A ZA904599 A ZA 904599A ZA 904599 A ZA904599 A ZA 904599A ZA 904599 B ZA904599 B ZA 904599B
Authority
ZA
South Africa
Prior art keywords
freeze dried
ester composition
stable freeze
polyhematoporphyrin
ether
Prior art date
Application number
ZA904599A
Other languages
English (en)
Inventor
Bruce E Haeger
E Haeger Bruce
James R Lawter
R Lawter James
Vijay H Naringrekar
H Naringrekar Vijay
Michael C Cucolo
C Cucolo Michael
Original Assignee
Quadra Logic Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quadra Logic Tech Inc filed Critical Quadra Logic Tech Inc
Publication of ZA904599B publication Critical patent/ZA904599B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA904599A 1989-06-14 1990-06-13 Stable freeze dried polyhematoporphyrin ether/ester composition ZA904599B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/366,374 US5059619A (en) 1989-06-14 1989-06-14 Stable freeze-dried polyhematoporphyrin ether/ester

Publications (1)

Publication Number Publication Date
ZA904599B true ZA904599B (en) 1991-04-24

Family

ID=23442747

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA904599A ZA904599B (en) 1989-06-14 1990-06-13 Stable freeze dried polyhematoporphyrin ether/ester composition

Country Status (26)

Country Link
US (1) US5059619A (es)
EP (1) EP0402637B1 (es)
JP (1) JP3112918B2 (es)
KR (1) KR0164845B1 (es)
CN (1) CN1058388C (es)
AR (1) AR244549A1 (es)
AT (1) ATE144703T1 (es)
AU (1) AU625549B2 (es)
CA (1) CA2018751C (es)
CZ (1) CZ283309B6 (es)
DD (1) DD295087A5 (es)
DE (1) DE69029012T2 (es)
DK (1) DK0402637T3 (es)
ES (1) ES2095846T3 (es)
FI (1) FI101597B1 (es)
GR (1) GR3021511T3 (es)
HU (1) HU215522B (es)
IE (1) IE902137A1 (es)
IL (1) IL94448A (es)
NO (1) NO176645C (es)
NZ (1) NZ233953A (es)
PL (1) PL164744B1 (es)
PT (1) PT94344B (es)
RU (1) RU2019990C1 (es)
TW (1) TW225475B (es)
ZA (1) ZA904599B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187572B1 (en) 1990-04-16 2001-02-13 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants
US5418130A (en) 1990-04-16 1995-05-23 Cryopharm Corporation Method of inactivation of viral and bacterial blood contaminants
US5244914A (en) * 1992-04-27 1993-09-14 American Cyanamid Company Stable porfimer sodium compositions and methods for their manufacture
NO180167C (no) 1994-09-08 1997-02-26 Photocure As Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
US5660181A (en) * 1994-12-12 1997-08-26 Physical Optics Corporation Hybrid neural network and multiple fiber probe for in-depth 3-D mapping
GB9512854D0 (en) * 1995-06-23 1995-08-23 Wellcome Found Novel formulation
US5958104A (en) * 1997-09-11 1999-09-28 Nonomura; Arthur M. Methods and compositions for enhancing plant growth
CA2221912A1 (en) * 1997-11-21 1999-05-21 David Dolphin Photosensitizers with improved biodistribution and light-absorbing properties
AU2002222104B2 (en) 2000-11-29 2007-06-28 Pci Biotech As Photochemical internalization for virus-mediated molecule delivery into the cyosol
AU2002220853B2 (en) 2000-11-29 2007-06-28 Pci Biotech As Photochemical internalization for delivery of molecules into the cytosol
US7175611B2 (en) 2002-06-05 2007-02-13 Mark Alan Mitchnick Antimicrobial release system
CN103961323B (zh) * 2013-02-05 2017-10-17 浙江海正药业股份有限公司 一种注射用hpph冻干粉针制剂及其制备方法
US9733187B2 (en) * 2015-03-06 2017-08-15 King Saud University Method of detecting bladder cancer by optical analysis of bodily fluids

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2858320A (en) * 1956-04-02 1958-10-28 Baxter Laboratories Inc Stable hematoporphyrin
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
US4753958A (en) * 1985-02-07 1988-06-28 University Of Cal Photochemotherapy of epithelial diseases with derivatives of hematoporphyrins
DE3688721T2 (de) * 1985-04-30 1993-12-16 Nippon Petrochemicals Co Ltd Verwendung von Porphyrinderivaten bei der Entdeckung und Behandlung von Tumoren.
US4882234A (en) * 1986-11-12 1989-11-21 Healux, Inc. Storage-stable porphin compositions and a method for their manufacture
US4968715A (en) * 1988-07-06 1990-11-06 Health Research, Inc. Use of purified hematoporphyrin trimers in photodynamic therapy

Also Published As

Publication number Publication date
NO176645C (no) 1995-05-10
KR0164845B1 (ko) 1999-01-15
AR244549A1 (es) 1993-11-30
HU215522B (hu) 1999-01-28
IL94448A (en) 1994-06-24
EP0402637A2 (en) 1990-12-19
IE902137L (en) 1990-12-14
KR910000146A (ko) 1991-01-29
RU2019990C1 (ru) 1994-09-30
PL164744B1 (pl) 1994-10-31
DE69029012T2 (de) 1997-02-27
NZ233953A (en) 1992-08-26
ES2095846T3 (es) 1997-03-01
AU5708990A (en) 1990-12-20
DD295087A5 (de) 1991-10-24
EP0402637A3 (en) 1991-04-03
NO902634L (no) 1990-12-17
AU625549B2 (en) 1992-07-16
FI101597B (fi) 1998-07-31
IE902137A1 (en) 1991-01-02
FI902966A0 (fi) 1990-06-13
CA2018751C (en) 2001-08-21
JP3112918B2 (ja) 2000-11-27
IL94448A0 (en) 1991-03-10
DK0402637T3 (da) 1997-04-07
HU903850D0 (en) 1990-11-28
EP0402637B1 (en) 1996-10-30
DE69029012D1 (de) 1996-12-05
CA2018751A1 (en) 1990-12-14
JPH0331283A (ja) 1991-02-12
TW225475B (es) 1994-06-21
CN1058388C (zh) 2000-11-15
US5059619A (en) 1991-10-22
GR3021511T3 (en) 1997-01-31
CS9002889A2 (en) 1991-11-12
NO902634D0 (no) 1990-06-13
ATE144703T1 (de) 1996-11-15
HUT54888A (en) 1991-04-29
FI101597B1 (fi) 1998-07-31
PT94344B (pt) 1997-04-30
CN1047973A (zh) 1990-12-26
NO176645B (no) 1995-01-30
PT94344A (pt) 1991-02-08
CZ283309B6 (cs) 1998-02-18

Similar Documents

Publication Publication Date Title
IL101007A (en) Dry stable compositions prepared by lyophilization
EP0423752A3 (en) Dielectric compositions
EP0412449A3 (en) Solid cosmetic composition
AR244549A1 (es) Metodo para preparar una composicion liolilizada con un contenido de humedad residual satisfactorio para el tratamiento o diagnostico fotodinamico de un paciente.
EP0428276A3 (en) Acaricidal composition
GB8923833D0 (en) Dry solid compositions containing lipid
GB8908361D0 (en) Composition
GB8912963D0 (en) Surfactant composition
HU900135D0 (en) New harbicid compositions
EP0386359A3 (en) Konjak-containing composition
GB8902762D0 (en) Surfactant composition
GB9028019D0 (en) All weather racetrack composition
GB2231575B (en) Command-curable composition
GB8916151D0 (en) Composition
GB2217175B (en) Dry solid compositions containing lipid
ZW9690A1 (en) Composition
LTIP786A (en) Stable arthropodical composition
ZA9010348B (en) Frying-fat composition
HU204716B (en) Raney-catalyzer composition
ZA9135B (en) All weather racetrack composition
ZA905862B (en) Ensiling composition
GB8904789D0 (en) Dermatological composition
ZA904368B (en) Composition
GB8929036D0 (en) Composition
BG47864A1 (en) Polvinylchloride composition